2017-03-16,Acceleron Announces Plans To Initiate A Phase 2 Trial Of ACE-083 In Charcot-Marie-Tooth Neuromuscular Disease And Host Educational Webinar
2017-03-02,Acceleron Pharma Price Target Raised by Leerink
2017-03-01,Acceleron Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results
2017-02-28,Acceleron To Participate In Two Healthcare Investor Conferences In March
2017-02-22,Acceleron Pharma To Webcast Conference Call Of Fourth Quarter And Year Ended 2016 Financial Results On March 1, 2017
2017-02-01,Acceleron To Participate In Two Healthcare Investor Conferences In February
2017-01-19,Acceleron Pharma Enters Oversold Territory (XLRN)
2017-01-06,Acceleron Outlines Corporate Goals And Priorities For 2017
2017-01-04,Acceleron To Webcast Presentation At 35th Annual J.P. Morgan Healthcare Conference
2016-12-22,Acceleron Announces First Patient Treated In Phase 2 Trial Of ACE-083 In Facioscapulohumeral Muscular Dystrophy
2016-12-07,Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
2016-12-05,Acceleron And Celgene Announce Updated Results From Phase 2 Studies Of Luspatercept In Beta-Thalassemia Presented At The 58th Annual Meeting Of The American Society Of Hematology
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-05,Acceleron And Celgene Announce Preliminary Results From An Investigator Initiated Phase 2 Study Of Sotatercept In Myelofibrosis At The 58th Annual Meeting Of The American Society Of Hematology
2016-12-04,Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment
2016-12-04,Acceleron And Celgene Announce Updated Results From Ongoing Phase 2 Studies Of Luspatercept In Myelodysplastic Syndromes At The 58th Annual Meeting Of The American Society Of Hematology
2016-11-30,Acceleron Pharma To Host Conference Call And Webcast To Review Data Presented At The 58th American Society Of Hematology Annual Meeting And Exposition
2016-11-03,Acceleron Pharma Reports Third Quarter 2016 Financial And Operational Results
2016-11-03,RSI Alert: Acceleron Pharma (XLRN) Now Oversold
2016-11-03,Acceleron Announces New Data Presentations At The 58th American Society Of Hematology Annual Meeting And Exposition
2016-11-02,Acceleron To Present At Credit Suisse Healthcare Conference Monday, November 7, 2016
2016-10-27,Acceleron Pharma To Webcast Conference Call Of Third Quarter 2016 Financial Results On November 3, 2016
2016-10-13,Acceleron To Host Educational Webcast On Facioscapulohumeral Muscular Dystrophy (FSHD) With Leading Researcher And Provide Overview Of ACE-083 Phase 2 Trial
2016-09-27,Acceleron Announces Retirement Of John Knopf As President And CEO; Habib Dable Named As Successor
2016-08-31,Acceleron To Participate In Three Healthcare Investor Conferences In September
2016-08-04,Acceleron Pharma Reports Second Quarter 2016 Financial And Operational Results
2016-07-28,Acceleron Pharma To Webcast Conference Call Of Second Quarter 2016 Financial Results On August 4, 2016
2016-07-25,Acceleron Pharma Appoints Thomas McCourt To Its Board Of Directors
2016-07-08,Acceleron Announces ACE-083 Phase 1 Results At The 14th International Congress On Neuromuscular Diseases
2016-07-07,Acceleron Pharma (XLRN) Showing Signs Of Perilous Reversal Today
2016-07-06,Acceleron Pharma (XLRN) Marked As A Dead Cat Bounce Stock
2016-06-29,Acceleron Announces Presentation Of ACE-083 Phase 1 Healthy Volunteer Data At The 14th International Congress On Neuromuscular Disease
2016-06-28,Brexit Bargain Buys: 14 More Stocks Picked by Morgan Stanley
2016-06-20,Acceleron Pharma (XLRN) Is Today's Dead Cat Bounce Stock
2016-06-10,Acceleron And Celgene Announce Updated Results From An Ongoing Phase 2 Study Of Luspatercept In Beta-Thalassemia Presented At The 21st Congress Of The European Hematology Association
2016-06-10,Acceleron And Celgene Announce Updated Results From An Ongoing Phase 2 Study Of Luspatercept In Myelodysplastic Syndromes At The 21st Congress Of The European Hematology Association
2016-06-07,Acceleron Pharma To Host Conference Call And Webcast To Review Updated Luspatercept Results Presented At The 21st Congress Of The European Hematology Association
2016-06-01,Acceleron Pharma To Participate In Two Healthcare Investor Conferences In June
2016-05-19,Acceleron Announces Data Presentations With Luspatercept At The 21st Congress Of The European Hematology Association
2016-05-05,Acceleron Pharma Reports First Quarter 2016 Financial And Operational Results
2016-04-28,Acceleron Pharma To Host First Quarter 2016 Financial Results
2016-04-26,Acceleron Pharma To Participate In Two Healthcare Investor Conferences In May
2016-04-25,Trade-Ideas: Acceleron Pharma (XLRN) Is Today's Strong On High Relative Volume Stock
2016-03-01,Acceleron Pharma To Participate In Four Healthcare Investor Conferences In March
2016-02-25,Acceleron Pharma Reports Fourth Quarter And Year Ended 2015 Financial And Operational Results And Recent Highlights
2016-02-21,19 Charts to Calm Your Recession Fears
2016-02-18,Acceleron Pharma To Host Fourth Quarter And Year Ended 2015 Financial Results
2016-02-14,19 Stocks You Should Own if the U.S. Falls Into a Recession
2016-02-03,Acceleron Pharma Enters Oversold Territory (XLRN)
2016-02-01,Acceleron Pharma To Participate In Two Healthcare Investor Conferences In February
2016-01-15,5 Stocks to Trade for Breakout Gains
2016-01-12,Insider Trading Alert - XLRN, TTMI And AGX Traded By Insiders
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-06,Acceleron Pharma (XLRN) Trading With Heavy Volume Before Market Open
2016-01-05,Acceleron Announces Pricing Of Public Offering Of Common Stock
2016-01-04,Acceleron Announces Proposed Public Offering Of Common Stock
2015-12-07,Celgene And Acceleron Announce New Results From An Investigational Study With Luspatercept In Beta-Thalassemia Presented At The 57th American Society Of Hematology (ASH) Annual Meeting And Exposition
2015-12-07,FDA Fast Track Designation Granted To Luspatercept For The Treatment Of Patients With Lower-Risk Myelodysplastic Syndromes
2015-12-07,Investors Remain Skeptical about Bluebird Gene Therapy for Blood Disease
2015-12-05,Celgene And Acceleron Announce New Results From An Investigational Study With Luspatercept In Myelodysplastic Syndromes Presented At The 57th American Society Of Hematology (ASH) Annual Meeting And Exposition
2015-12-01,Acceleron Announces Oral Plenary Presentation For ACE-083 In The Late Breaking Clinical Trials Session At The 8th International Conference On Cachexia, Sarcopenia And Muscle Wasting
2015-11-24,Acceleron Pharma To Present At Piper Jaffray 27th Annual Healthcare Conference
2015-11-05,Acceleron Announces New Data Presentations At The 2015 American Society Of Hematology Annual Meeting
2015-11-04,Acceleron Pharma Reports Third Quarter 2015 Financial And Operational Results
2015-11-02,Acceleron Pharma To Present At Upcoming Investor Conferences In November
2015-10-29,Acceleron Pharma To Host Third Quarter 2015 Financial Results Conference Call And Webcast On November 4, 2015
2015-10-23,Acceleron Highlights Phase 3 Studies, New Clinical Results And Research Strategies At Research And Development Day Event
2015-10-15,Acceleron To Host Research And Development Day On October 23
2015-10-05,Commit To Buy Acceleron Pharma At $20, Earn 24% Annualized Using Options
2015-10-02,Acceleron Announces Presentation Of Sotatercept Data At The American Society Of Nephrology Kidney Week 2015
2015-10-01,Acceleron Presents Preclinical Data For ACE-083 And ACE-2494 At The 20th International Annual Congress Of The World Muscle Society
2015-09-24,Trade-Ideas: Acceleron Pharma (XLRN) Is Today's Weak On High Relative Volume Stock
2015-09-02,Acceleron Pharma To Present At Upcoming Investor Conferences In September
2015-08-14,Acceleron Pharma (XLRN) Highlighted As Weak On High Volume
2015-08-06,Acceleron Pharma Reports Second Quarter 2015 Financial And Operational Results
2015-07-29,Acceleron Pharma To Host Second Quarter 2015 Financial Results Conference Call And Webcast On August 6, 2015
2015-07-06,Commit To Purchase Acceleron Pharma At $25, Earn 14.1% Annualized Using Options
2015-06-15,Acceleron Announces Publication In Cancer Research Demonstrating Dalantercept Prevents Metastases In Preclinical Studies Of Breast Cancer
2015-06-12,Acceleron Announces New Luspatercept Phase 2 Clinical Results At The 20th Congress Of The European Hematology Association
2015-06-09,Acceleron Pharma To Host Conference Call And Webcast To Review New Luspatercept Data Presented At The 20th Congress Of The European Hematology Association
2015-05-27,Acceleron Pharma To Present At Upcoming Investor Conferences In June
2015-05-21,Acceleron To Present Luspatercept Clinical Trials At The 20th Congress Of The European Hematology Association
2015-05-18,(Graphic: Business Wire)
2015-05-14,Trade-Ideas: Acceleron Pharma (XLRN) Is Today's Weak On High Relative Volume Stock
2015-05-13,Acceleron To Present Dalantercept Clinical Data At The 2015 American Society Of Clinical Oncology (ASCO) Annual Meeting
2015-05-07,Acceleron Pharma Reports First Quarter 2015 Financial And Operational Results
2015-05-02,Luspatercept Data Presented At The 13th International Symposium On Myelodysplastic Syndromes
2015-04-30,Celgene And Acceleron Select Luspatercept To Advance To Phase 3 In Myelodysplastic Syndromes
2015-04-28,Acceleron Pharma To Host First Quarter 2015 Financial Results Conference Call And Webcast On May 7, 2015
2015-04-27,Oversold Conditions For Acceleron Pharma
2015-04-23,Acceleron Pharma To Present At Upcoming Investor Conferences In May
2015-04-07,Acceleron Announces Oral Presentations Of Luspatercept And Sotatercept Data At The 13th International Symposium On Myelodysplastic Syndromes
2015-04-06,Interesting XLRN Put And Call Options For August 21st
2015-04-06,Acceleron Pharma Appoints Dr. Francois Nader As Chairman Of Its Board Of Directors
2015-03-06,Acceleron Pharma Announces Executive Appointments And Promotions
2015-03-02,Acceleron Pharma Reports Fourth Quarter And Year Ended 2014 Financial And Operational Results
2015-02-28,Acceleron Presents Encouraging Response Rates And Progression-Free Survival Data In Patients With Advanced Renal Cell Carcinoma At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium
2015-02-26,Acceleron Pharma To Present At Upcoming Investor Conferences In March
2015-02-24,Acceleron Pharma To Host Fourth Quarter And Year Ended 2014 Financial Results Conference Call And Webcast On March 2, 2015
2015-02-19,Acceleron To Present New Dalantercept Clinical Data At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium
2015-01-28,Acceleron Pharma To Present At Upcoming Investor Conferences In February
2015-01-14,Insider Trading Alert - XLRN, MOH And PF Traded By Insiders
2015-01-12,Celgene Has 2020 Vision for Long-Term Growth but Plays Safe for 2017
2015-01-12,Insider Trading Alert - EXA, CVV And XLRN Traded By Insiders
2015-01-12,Acceleron Pharma Outlines Corporate Objectives For 2015
2014-12-24,Commit To Purchase Acceleron Pharma At $30, Earn 16.7% Annualized Using Options
2014-12-15,Acceleron Pharma Added To NASDAQ Biotechnology Index
2014-12-12,Acceleron Pharma Appoints Dr. Francois Nader To Its Board Of Directors
2014-12-10,Luspatercept Data On Myelodysplastic Syndromes Selected For "Best Of ASH" By The American Society Of Hematology
2014-12-08,New Data In Myelodysplastic Syndromes Presented At The 56th American Society Of Hematology (ASH) Annual Meeting And Exposition
2014-12-08,Acceleron Pharma (XLRN) Strong On High Relative Volume Today
2014-12-08,The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
2014-12-07,Acceleron Drugs Reduce Anemia Caused by Rare Blood Disorders
2014-12-07,New Data From Luspatercept Phase 2 Clinical Trial In Beta-Thalassemia Presented At The 56th American Society Of Hematology (ASH) Annual Meeting And Exposition
2014-11-24,Acceleron Pharma To Present At Upcoming Investor Conferences In December
2014-11-13,Sotatercept Data From The Phase 2a Clinical Trial In Hemodialysis Patients Presented At The American Society Of Nephrology Kidney Week 2014
2014-11-11,Ratings Changes Today
2014-11-07,Acceleron Pharma Reports Third Quarter 2014 Financial And Operational Results
2014-11-06,Acceleron Announces New Clinical Data Presentations At The 2014 American Society Of Hematology Annual Meeting
2014-10-30,Acceleron Pharma To Host Third Quarter 2014 Financial Results Conference Call And Webcast On November 7, 2014
2014-10-29,Acceleron Pharma To Present At Upcoming Investor Conferences In November
2014-10-23,Acceleron Collaboration Partner Celgene To Present Data At The American Society Of Nephrology Kidney Week 2014
2014-10-22,Acceleron Announces Educational Webcast On Chronic Kidney Disease - Mineral And Bone Disorder
2014-10-14,Acceleron Initiates Phase 1 Clinical Trial With Innovative Muscle Drug ACE-083
2014-10-02,Acceleron Hit Over Competitive Concerns, but Investors Overlook Rest of Pipeline
2014-10-01,Acceleron To Host Educational Webcast On Beta-thalassemia
2014-09-29,Acceleron To Webcast Presentation At Leerink Partners Rare Disease Roundtable
2014-09-23,Acceleron Provides Update On Externally Sponsored Clinical Trial Of Dalantercept Monotherapy In Ovarian Cancer
2014-09-16,Acceleron To Host Educational Webcast Series With Clinical Thought Leaders
2014-08-27,Acceleron Pharma To Present At Upcoming Investor Conferences In September
2014-08-12,Acceleron Pharma Reports Second Quarter 2014 Financial Results
2014-08-05,Acceleron Pharma To Host Second Quarter 2014 Financial Results
2014-07-17,Acceleron Pharma Enters Oversold Territory (XLRN)
2014-07-14,Acceleron Pharma Appoints Terrence C. Kearney To Its Board Of Directors
2014-06-19,Acceleron Pharma To Present At JMP Securities Healthcare Conference
2014-06-14,Studies Presented At 19th European Hematology Association Annual Congress Evaluate Activin Receptor Ligand Trap Programs In Beta-Thalassemia
2014-06-10,3 Stocks Spiking on Unusual Volume
2014-05-29,Acceleron Pharma To Present At Upcoming Investor And Medical Conferences In June
2014-05-21,Acceleron Announces New Interim Phase 2 Data On Sotatercept And ACE-536 To Be Reported At Three Oral Presentations At The 19th Annual Congress Of The European Hematology Association
2014-05-15,Acceleron Pharma Reports First Quarter 2014 Financial Results
2014-05-14,Acceleron To Report New Encouraging Interim Clinical Data From Phase 2 Trial Of Dalantercept In Renal Cell Carcinoma At The 50th Annual Meeting Of The American Society Of Clinical Oncology
2014-05-12,Acceleron To Present At 2014 UBS Global Healthcare Conference
2014-05-08,Acceleron Pharma To Host First Quarter 2014 Financial Results Conference Call And Webcast On May 15, 2014
2014-04-23,Acceleron And Celgene Announce Interim Clinical Data For Sotatercept Demonstrating Dose Dependent Increases In Hemoglobin In Patients With End Stage Renal Disease On Hemodialysis
2014-03-28,'Fast Money' Recap: Downward Pressure
2014-03-24,Acceleron, Celgene And Collaborators Announce Two Publications In Nature Medicine Describing Sotatercept And ACE-536 Therapeutic Potential In Beta-thalassemia And Myelodysplastic Syndromes
2014-03-20,Acceleron To Present At The 21st Annual Future Leaders In The Biotech Industry Conference
2014-03-17,Acceleron And Celgene Announce Interim Clinical Data For Sotatercept In Patients With End Stage Renal Disease On Hemodialysis At The 2014 National Kidney Foundation Spring Clinical Meeting
2014-02-27,Acceleron To Present At Cowen And Company 34th Annual Health Care Conference
2014-02-26,Acceleron Pharma Reports Fourth Quarter And Year Ended 2013 Financial Results
2014-02-19,Acceleron Pharma To Host Fourth Quarter And Year Ended 2013 Financial Results Conference Call And Webcast On February 26, 2014
2014-02-05,Acceleron To Present At 2014 Leerink Global Healthcare Conference
2014-01-30,Top Insider Trades: XLRN AYR SVVC OPK
2014-01-28,Acceleron Announces Closing Of Public Offering And Full Exercise Of Underwriters&#8217; Option To Purchase Additional Shares
2014-01-23,The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
2014-01-22,Acceleron Announces Pricing Of Public Offering Of Common Stock
2014-01-21,Acceleron Commences Proposed Public Offering Of Common Stock
2014-01-09,Acceleron Files Registration Statement For Proposed Public Offering Of Common Stock
2013-12-23,3 Biotech Stocks Spiking on Big Volume
2013-12-20,Acceleron Pharma To Be Added To Russell 2000&#174; Index
2013-12-18,Acceleron Earns $7 Million Milestone Payment For Celgene&#8217;s Initiation Of Sotatercept Phase 2 Clinical Trial In Patients With End Stage Renal Disease On Hemodialysis
2013-12-09,Acceleron And Celgene Report New Interim Clinical Data From Phase 2 Trial Of Sotatercept In Beta-Thalassemia At 2013 American Society Of Hematology Annual Meeting
2013-12-03,Acceleron Pharma Provides Update On Clinical Pipeline At Piper Jaffray Healthcare Conference
2013-12-02,Acceleron Announces New Interim Phase 2 Sotatercept Clinical Data In Beta-Thalassemia To Be Presented At 2013 American Society Of Hematology Annual Meeting
2013-11-25,Acceleron To Present At Piper Jaffray Healthcare Conference In December
2013-11-06,Acceleron Pharma Reports Third Quarter 2013 Financial Results
2013-11-05,Acceleron Pharma To Ring The NASDAQ Stock Market Closing Bell On November 5, 2013
2013-10-30,Acceleron Pharma To Host Third Quarter 2013 Financial Results Conference Call And Webcast On November 6, 2013
2013-10-22,Flagship VentureLabs™ Launches Pronutria To Prevent And Treat Diseases With Novel Protein Nutrients
2013-09-27,Top Insider Trades: NSH KAR XLRN IMH
2013-09-24,Acceleron Announces Closing Of Initial Public Offering And Full-Exercise Of Over-Allotment Option
2013-09-18,BioTech IPOs With Big Partners
2017-03-16,Acceleron Announces Plans To Initiate A Phase 2 Trial Of ACE-083 In Charcot-Marie-Tooth Neuromuscular Disease And Host Educational Webinar
2017-03-02,Acceleron Pharma Price Target Raised by Leerink
2017-03-01,Acceleron Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results
2017-02-28,Acceleron To Participate In Two Healthcare Investor Conferences In March
2017-02-22,Acceleron Pharma To Webcast Conference Call Of Fourth Quarter And Year Ended 2016 Financial Results On March 1, 2017
2017-02-01,Acceleron To Participate In Two Healthcare Investor Conferences In February
2017-01-19,Acceleron Pharma Enters Oversold Territory (XLRN)
2017-01-06,Acceleron Outlines Corporate Goals And Priorities For 2017
2017-01-04,Acceleron To Webcast Presentation At 35th Annual J.P. Morgan Healthcare Conference
2016-12-22,Acceleron Announces First Patient Treated In Phase 2 Trial Of ACE-083 In Facioscapulohumeral Muscular Dystrophy
2016-12-07,Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
2016-12-05,Acceleron And Celgene Announce Updated Results From Phase 2 Studies Of Luspatercept In Beta-Thalassemia Presented At The 58th Annual Meeting Of The American Society Of Hematology
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-05,Acceleron And Celgene Announce Preliminary Results From An Investigator Initiated Phase 2 Study Of Sotatercept In Myelofibrosis At The 58th Annual Meeting Of The American Society Of Hematology
2016-12-04,Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment
2016-12-04,Acceleron And Celgene Announce Updated Results From Ongoing Phase 2 Studies Of Luspatercept In Myelodysplastic Syndromes At The 58th Annual Meeting Of The American Society Of Hematology
2016-11-30,Acceleron Pharma To Host Conference Call And Webcast To Review Data Presented At The 58th American Society Of Hematology Annual Meeting And Exposition
2016-11-03,Acceleron Pharma Reports Third Quarter 2016 Financial And Operational Results
2016-11-03,RSI Alert: Acceleron Pharma (XLRN) Now Oversold
2016-11-03,Acceleron Announces New Data Presentations At The 58th American Society Of Hematology Annual Meeting And Exposition
2016-11-02,Acceleron To Present At Credit Suisse Healthcare Conference Monday, November 7, 2016
2016-10-27,Acceleron Pharma To Webcast Conference Call Of Third Quarter 2016 Financial Results On November 3, 2016
2016-10-13,Acceleron To Host Educational Webcast On Facioscapulohumeral Muscular Dystrophy (FSHD) With Leading Researcher And Provide Overview Of ACE-083 Phase 2 Trial
2016-09-27,Acceleron Announces Retirement Of John Knopf As President And CEO; Habib Dable Named As Successor
2016-08-31,Acceleron To Participate In Three Healthcare Investor Conferences In September
2016-08-04,Acceleron Pharma Reports Second Quarter 2016 Financial And Operational Results
2016-07-28,Acceleron Pharma To Webcast Conference Call Of Second Quarter 2016 Financial Results On August 4, 2016
2016-07-25,Acceleron Pharma Appoints Thomas McCourt To Its Board Of Directors
2016-07-08,Acceleron Announces ACE-083 Phase 1 Results At The 14th International Congress On Neuromuscular Diseases
2016-07-07,Acceleron Pharma (XLRN) Showing Signs Of Perilous Reversal Today
2016-07-06,Acceleron Pharma (XLRN) Marked As A Dead Cat Bounce Stock
2016-06-29,Acceleron Announces Presentation Of ACE-083 Phase 1 Healthy Volunteer Data At The 14th International Congress On Neuromuscular Disease
2016-06-28,Brexit Bargain Buys: 14 More Stocks Picked by Morgan Stanley
2016-06-20,Acceleron Pharma (XLRN) Is Today's Dead Cat Bounce Stock
2016-06-10,Acceleron And Celgene Announce Updated Results From An Ongoing Phase 2 Study Of Luspatercept In Beta-Thalassemia Presented At The 21st Congress Of The European Hematology Association
2016-06-10,Acceleron And Celgene Announce Updated Results From An Ongoing Phase 2 Study Of Luspatercept In Myelodysplastic Syndromes At The 21st Congress Of The European Hematology Association
2016-06-07,Acceleron Pharma To Host Conference Call And Webcast To Review Updated Luspatercept Results Presented At The 21st Congress Of The European Hematology Association
2016-06-01,Acceleron Pharma To Participate In Two Healthcare Investor Conferences In June
2016-05-19,Acceleron Announces Data Presentations With Luspatercept At The 21st Congress Of The European Hematology Association
2016-05-05,Acceleron Pharma Reports First Quarter 2016 Financial And Operational Results
2016-04-28,Acceleron Pharma To Host First Quarter 2016 Financial Results
2016-04-26,Acceleron Pharma To Participate In Two Healthcare Investor Conferences In May
2016-04-25,Trade-Ideas: Acceleron Pharma (XLRN) Is Today's Strong On High Relative Volume Stock
2016-03-01,Acceleron Pharma To Participate In Four Healthcare Investor Conferences In March
2016-02-25,Acceleron Pharma Reports Fourth Quarter And Year Ended 2015 Financial And Operational Results And Recent Highlights
2016-02-21,19 Charts to Calm Your Recession Fears
2016-02-18,Acceleron Pharma To Host Fourth Quarter And Year Ended 2015 Financial Results
2016-02-14,19 Stocks You Should Own if the U.S. Falls Into a Recession
2016-02-03,Acceleron Pharma Enters Oversold Territory (XLRN)
2016-02-01,Acceleron Pharma To Participate In Two Healthcare Investor Conferences In February
2016-01-15,5 Stocks to Trade for Breakout Gains
2016-01-12,Insider Trading Alert - XLRN, TTMI And AGX Traded By Insiders
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-06,Acceleron Pharma (XLRN) Trading With Heavy Volume Before Market Open
2016-01-05,Acceleron Announces Pricing Of Public Offering Of Common Stock
2016-01-04,Acceleron Announces Proposed Public Offering Of Common Stock
2015-12-07,Celgene And Acceleron Announce New Results From An Investigational Study With Luspatercept In Beta-Thalassemia Presented At The 57th American Society Of Hematology (ASH) Annual Meeting And Exposition
2015-12-07,FDA Fast Track Designation Granted To Luspatercept For The Treatment Of Patients With Lower-Risk Myelodysplastic Syndromes
2015-12-07,Investors Remain Skeptical about Bluebird Gene Therapy for Blood Disease
2015-12-05,Celgene And Acceleron Announce New Results From An Investigational Study With Luspatercept In Myelodysplastic Syndromes Presented At The 57th American Society Of Hematology (ASH) Annual Meeting And Exposition
2015-12-01,Acceleron Announces Oral Plenary Presentation For ACE-083 In The Late Breaking Clinical Trials Session At The 8th International Conference On Cachexia, Sarcopenia And Muscle Wasting
2015-11-24,Acceleron Pharma To Present At Piper Jaffray 27th Annual Healthcare Conference
2015-11-05,Acceleron Announces New Data Presentations At The 2015 American Society Of Hematology Annual Meeting
2015-11-04,Acceleron Pharma Reports Third Quarter 2015 Financial And Operational Results
2015-11-02,Acceleron Pharma To Present At Upcoming Investor Conferences In November
2015-10-29,Acceleron Pharma To Host Third Quarter 2015 Financial Results Conference Call And Webcast On November 4, 2015
2015-10-23,Acceleron Highlights Phase 3 Studies, New Clinical Results And Research Strategies At Research And Development Day Event
2015-10-15,Acceleron To Host Research And Development Day On October 23
2015-10-05,Commit To Buy Acceleron Pharma At $20, Earn 24% Annualized Using Options
2015-10-02,Acceleron Announces Presentation Of Sotatercept Data At The American Society Of Nephrology Kidney Week 2015
2015-10-01,Acceleron Presents Preclinical Data For ACE-083 And ACE-2494 At The 20th International Annual Congress Of The World Muscle Society
2015-09-24,Trade-Ideas: Acceleron Pharma (XLRN) Is Today's Weak On High Relative Volume Stock
2015-09-02,Acceleron Pharma To Present At Upcoming Investor Conferences In September
2015-08-14,Acceleron Pharma (XLRN) Highlighted As Weak On High Volume
2015-08-06,Acceleron Pharma Reports Second Quarter 2015 Financial And Operational Results
2015-07-29,Acceleron Pharma To Host Second Quarter 2015 Financial Results Conference Call And Webcast On August 6, 2015
2015-07-06,Commit To Purchase Acceleron Pharma At $25, Earn 14.1% Annualized Using Options
2015-06-15,Acceleron Announces Publication In Cancer Research Demonstrating Dalantercept Prevents Metastases In Preclinical Studies Of Breast Cancer
2015-06-12,Acceleron Announces New Luspatercept Phase 2 Clinical Results At The 20th Congress Of The European Hematology Association
2015-06-09,Acceleron Pharma To Host Conference Call And Webcast To Review New Luspatercept Data Presented At The 20th Congress Of The European Hematology Association
2015-05-27,Acceleron Pharma To Present At Upcoming Investor Conferences In June
2015-05-21,Acceleron To Present Luspatercept Clinical Trials At The 20th Congress Of The European Hematology Association
2015-05-18,(Graphic: Business Wire)
2015-05-14,Trade-Ideas: Acceleron Pharma (XLRN) Is Today's Weak On High Relative Volume Stock
2015-05-13,Acceleron To Present Dalantercept Clinical Data At The 2015 American Society Of Clinical Oncology (ASCO) Annual Meeting
2015-05-07,Acceleron Pharma Reports First Quarter 2015 Financial And Operational Results
2015-05-02,Luspatercept Data Presented At The 13th International Symposium On Myelodysplastic Syndromes
2015-04-30,Celgene And Acceleron Select Luspatercept To Advance To Phase 3 In Myelodysplastic Syndromes
2015-04-28,Acceleron Pharma To Host First Quarter 2015 Financial Results Conference Call And Webcast On May 7, 2015
2015-04-27,Oversold Conditions For Acceleron Pharma
2015-04-23,Acceleron Pharma To Present At Upcoming Investor Conferences In May
2015-04-07,Acceleron Announces Oral Presentations Of Luspatercept And Sotatercept Data At The 13th International Symposium On Myelodysplastic Syndromes
2015-04-06,Interesting XLRN Put And Call Options For August 21st
2015-04-06,Acceleron Pharma Appoints Dr. Francois Nader As Chairman Of Its Board Of Directors
2015-03-06,Acceleron Pharma Announces Executive Appointments And Promotions
2015-03-02,Acceleron Pharma Reports Fourth Quarter And Year Ended 2014 Financial And Operational Results
2015-02-28,Acceleron Presents Encouraging Response Rates And Progression-Free Survival Data In Patients With Advanced Renal Cell Carcinoma At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium
2015-02-26,Acceleron Pharma To Present At Upcoming Investor Conferences In March
2015-02-24,Acceleron Pharma To Host Fourth Quarter And Year Ended 2014 Financial Results Conference Call And Webcast On March 2, 2015
2015-02-19,Acceleron To Present New Dalantercept Clinical Data At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium
2015-01-28,Acceleron Pharma To Present At Upcoming Investor Conferences In February
2015-01-14,Insider Trading Alert - XLRN, MOH And PF Traded By Insiders
2015-01-12,Celgene Has 2020 Vision for Long-Term Growth but Plays Safe for 2017
2015-01-12,Insider Trading Alert - EXA, CVV And XLRN Traded By Insiders
2015-01-12,Acceleron Pharma Outlines Corporate Objectives For 2015
2014-12-24,Commit To Purchase Acceleron Pharma At $30, Earn 16.7% Annualized Using Options
2014-12-15,Acceleron Pharma Added To NASDAQ Biotechnology Index
2014-12-12,Acceleron Pharma Appoints Dr. Francois Nader To Its Board Of Directors
2014-12-10,Luspatercept Data On Myelodysplastic Syndromes Selected For "Best Of ASH" By The American Society Of Hematology
2014-12-08,New Data In Myelodysplastic Syndromes Presented At The 56th American Society Of Hematology (ASH) Annual Meeting And Exposition
2014-12-08,Acceleron Pharma (XLRN) Strong On High Relative Volume Today
2014-12-08,The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
2014-12-07,Acceleron Drugs Reduce Anemia Caused by Rare Blood Disorders
2014-12-07,New Data From Luspatercept Phase 2 Clinical Trial In Beta-Thalassemia Presented At The 56th American Society Of Hematology (ASH) Annual Meeting And Exposition
2014-11-24,Acceleron Pharma To Present At Upcoming Investor Conferences In December
2014-11-13,Sotatercept Data From The Phase 2a Clinical Trial In Hemodialysis Patients Presented At The American Society Of Nephrology Kidney Week 2014
2014-11-11,Ratings Changes Today
2014-11-07,Acceleron Pharma Reports Third Quarter 2014 Financial And Operational Results
2014-11-06,Acceleron Announces New Clinical Data Presentations At The 2014 American Society Of Hematology Annual Meeting
2014-10-30,Acceleron Pharma To Host Third Quarter 2014 Financial Results Conference Call And Webcast On November 7, 2014
2014-10-29,Acceleron Pharma To Present At Upcoming Investor Conferences In November
2014-10-23,Acceleron Collaboration Partner Celgene To Present Data At The American Society Of Nephrology Kidney Week 2014
2014-10-22,Acceleron Announces Educational Webcast On Chronic Kidney Disease - Mineral And Bone Disorder
2014-10-14,Acceleron Initiates Phase 1 Clinical Trial With Innovative Muscle Drug ACE-083
2014-10-02,Acceleron Hit Over Competitive Concerns, but Investors Overlook Rest of Pipeline
2014-10-01,Acceleron To Host Educational Webcast On Beta-thalassemia
2014-09-29,Acceleron To Webcast Presentation At Leerink Partners Rare Disease Roundtable
2014-09-23,Acceleron Provides Update On Externally Sponsored Clinical Trial Of Dalantercept Monotherapy In Ovarian Cancer
2014-09-16,Acceleron To Host Educational Webcast Series With Clinical Thought Leaders
2014-08-27,Acceleron Pharma To Present At Upcoming Investor Conferences In September
2014-08-12,Acceleron Pharma Reports Second Quarter 2014 Financial Results
2014-08-05,Acceleron Pharma To Host Second Quarter 2014 Financial Results
2014-07-17,Acceleron Pharma Enters Oversold Territory (XLRN)
2014-07-14,Acceleron Pharma Appoints Terrence C. Kearney To Its Board Of Directors
2014-06-19,Acceleron Pharma To Present At JMP Securities Healthcare Conference
2014-06-14,Studies Presented At 19th European Hematology Association Annual Congress Evaluate Activin Receptor Ligand Trap Programs In Beta-Thalassemia
2014-06-10,3 Stocks Spiking on Unusual Volume
2014-05-29,Acceleron Pharma To Present At Upcoming Investor And Medical Conferences In June
2014-05-21,Acceleron Announces New Interim Phase 2 Data On Sotatercept And ACE-536 To Be Reported At Three Oral Presentations At The 19th Annual Congress Of The European Hematology Association
2014-05-15,Acceleron Pharma Reports First Quarter 2014 Financial Results
2014-05-14,Acceleron To Report New Encouraging Interim Clinical Data From Phase 2 Trial Of Dalantercept In Renal Cell Carcinoma At The 50th Annual Meeting Of The American Society Of Clinical Oncology
2014-05-12,Acceleron To Present At 2014 UBS Global Healthcare Conference
2014-05-08,Acceleron Pharma To Host First Quarter 2014 Financial Results Conference Call And Webcast On May 15, 2014
2014-04-23,Acceleron And Celgene Announce Interim Clinical Data For Sotatercept Demonstrating Dose Dependent Increases In Hemoglobin In Patients With End Stage Renal Disease On Hemodialysis
2014-03-28,'Fast Money' Recap: Downward Pressure
2014-03-24,Acceleron, Celgene And Collaborators Announce Two Publications In Nature Medicine Describing Sotatercept And ACE-536 Therapeutic Potential In Beta-thalassemia And Myelodysplastic Syndromes
2014-03-20,Acceleron To Present At The 21st Annual Future Leaders In The Biotech Industry Conference
2014-03-17,Acceleron And Celgene Announce Interim Clinical Data For Sotatercept In Patients With End Stage Renal Disease On Hemodialysis At The 2014 National Kidney Foundation Spring Clinical Meeting
2014-02-27,Acceleron To Present At Cowen And Company 34th Annual Health Care Conference
2014-02-26,Acceleron Pharma Reports Fourth Quarter And Year Ended 2013 Financial Results
2014-02-19,Acceleron Pharma To Host Fourth Quarter And Year Ended 2013 Financial Results Conference Call And Webcast On February 26, 2014
2014-02-05,Acceleron To Present At 2014 Leerink Global Healthcare Conference
2014-01-30,Top Insider Trades: XLRN AYR SVVC OPK
2014-01-28,Acceleron Announces Closing Of Public Offering And Full Exercise Of Underwriters&#8217; Option To Purchase Additional Shares
2014-01-23,The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
2014-01-22,Acceleron Announces Pricing Of Public Offering Of Common Stock
2014-01-21,Acceleron Commences Proposed Public Offering Of Common Stock
2014-01-09,Acceleron Files Registration Statement For Proposed Public Offering Of Common Stock
2013-12-23,3 Biotech Stocks Spiking on Big Volume
2013-12-20,Acceleron Pharma To Be Added To Russell 2000&#174; Index
2013-12-18,Acceleron Earns $7 Million Milestone Payment For Celgene&#8217;s Initiation Of Sotatercept Phase 2 Clinical Trial In Patients With End Stage Renal Disease On Hemodialysis
2013-12-09,Acceleron And Celgene Report New Interim Clinical Data From Phase 2 Trial Of Sotatercept In Beta-Thalassemia At 2013 American Society Of Hematology Annual Meeting
2013-12-03,Acceleron Pharma Provides Update On Clinical Pipeline At Piper Jaffray Healthcare Conference
2013-12-02,Acceleron Announces New Interim Phase 2 Sotatercept Clinical Data In Beta-Thalassemia To Be Presented At 2013 American Society Of Hematology Annual Meeting
2013-11-25,Acceleron To Present At Piper Jaffray Healthcare Conference In December
2013-11-06,Acceleron Pharma Reports Third Quarter 2013 Financial Results
2013-11-05,Acceleron Pharma To Ring The NASDAQ Stock Market Closing Bell On November 5, 2013
2013-10-30,Acceleron Pharma To Host Third Quarter 2013 Financial Results Conference Call And Webcast On November 6, 2013
2013-10-22,Flagship VentureLabs™ Launches Pronutria To Prevent And Treat Diseases With Novel Protein Nutrients
2013-09-27,Top Insider Trades: NSH KAR XLRN IMH
2013-09-24,Acceleron Announces Closing Of Initial Public Offering And Full-Exercise Of Over-Allotment Option
2013-09-18,BioTech IPOs With Big Partners
